Anne Li April 29th, 2017
On Friday, April 28th, a team of Chinese scientists used the cutting-edge gene-editing technique CRISPR-Cas9 on humans for the second time in history, injecting a cancer patient with modified human genes in hopes of vanquishing the disease. In the US, the first planned trials to use CRISPR in people still have not gotten under way. But in China, things appear to be moving relatively quickly. Last fall, a team at Sichuan University’s West China Hospital used CRISPR for the first time on an adult with lung cancer. In the new trial, reported by The Wall Street Journal, altered genes were injected into a patient with a rare type of head and neck cancer, called nasopharyngeal carcinoma, at Nanjing University’s Nanjing Drum Tower Hospital.
See original article at: http://gizmodo.com/china-is-racing-ahead-of-the-us-in-the-quest-to-cure-ca-1794749183